We presented data from cohort 1, 2 & 3 of TROPHY-U01 trial (manuscripts coming soon): Cohort 3 with SG/pembro showed ORR 41%, CR 20%, mDOR ~ 11 mo, mPFS ~ 5mo, mOS ~ 13 months; toxicity profile as expected with either agent alone; data support further evaluation of the combo
The Center for Medicare and Medicaid Innovation’s new Quality Pathway will align model design around quality goals, elevate outcomes and experience measures, and ensure that…
Pulmonary and critical care fellows can participate in CHEST Challenge to win prizes, including free registration to the CHEST annual meeting. Learn how to get…
Researchers aimed to evaluate the impact of childhood and adolescent chronic plaque psoriasis on the quality of life of parents and caregivers.
prostate cancer, advanced prostate cancer, androgen deprivation therapy (ADT), Relugolix, Dosing of Relugolix, gonadotropin-releasing hormone (GnRH) receptor antagonist, HERO study, abiraterone acetate, apalutamide, metastatic castration-sensitive…
On April 24, 2024, the Supreme Court will hear the second case this term involving access to abortion: Idaho v. United States. At stake in…
The FDA approved nogapendekin alfa inbakicept-pmln plus Bacillus Calmette-Guerin for the treatment of certain patients with bladder cancer, according to a press release from the…
Breast cancer in men is rare, representing just 1% of all breast cancers diagnosed per year. Men are often diagnosed later and have larger tumors…
“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.
New AMA data shows which physician specialties have the highest rates of burnout. Learn more from the AMA’s exclusive survey data.
”Zero-degree positioning” may be one of the most important first steps in managing large vessel occlusions, study shows.
